Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Pharmaceutical use of aescin and its salts

A technology of aescin and medicine, which is applied in the field of pharmaceutical use of aescin and its salts, and can solve problems such as inability to relieve abnormal urination, inability to cure pain, etc.

Active Publication Date: 2016-05-11
WUHAN AIMIN PHARMA
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] Oral or injection of aescin and its salts are commonly used clinically to treat cerebral edema caused by various reasons and accompanying brain dysfunction, inflammation and swelling caused by various reasons (such as trauma, burns, surgery), and venous reflux disorder It has strong anti-inflammatory and anti-exudation effects, and can significantly reduce the exudation of acute inflammation. However, whether aescin and its salts have the effect of treating chronic non-bacterial prostatitis has not been reported in the literature.
Most of the existing therapeutic drugs are symptomatic treatment. For example, the main function of anti-inflammatory drugs is to relieve pain, but cannot relieve abnormal urination such as urgency, frequency, dysuria, and nocturia; M-receptor blockers are used to relieve urinary symptoms. Urgency, frequent urination and nocturia, but can not cure pain; while antibiotics are mainly for inflammatory chronic prostatitis, but only about 5% of patients with chronic prostatitis have definite bacterial infection; in contrast, α-receptor blockers For example, phenoxybenzamine hydrochloride and naftopidil can relax the smooth muscles of the prostate and bladder and improve lower urinary tract symptoms and pain, so they have become basic drugs for the treatment of chronic non-bacterial prostatitis

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical use of aescin and its salts
  • Pharmaceutical use of aescin and its salts
  • Pharmaceutical use of aescin and its salts

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1 7

[0016] Non-clinical pharmacodynamics study of embodiment 1 aescin sodium

[0017] 1. Experimental materials

[0018] 1.1 Experimental drugs

[0019] Drug: sodium aescinate, white freeze-dried loose block, used 0.9% sodium chloride injection to make sodium aescinate respectively in the experiment, 2.0mg / ml, 1.5mg / ml and 1.0mg / ml solutions .

[0020] Positive control drug: Zhulinamine (phenoxybenzamine hydrochloride tablet), tablet, 5mg / tablet, produced by Henan Tailong Pharmaceutical Co., Ltd. Yuzhong Pharmaceutical Factory. Approval number: Guoyao Zhunzi H10910024.

[0021] Modeling drug: estradiol benzoate injection, produced by Hangzhou Animal Pharmaceutical Factory. Approval number: Veterinary Medicine (2008) 110202511. Specifications: 2ml: 4mg.

[0022] Penicillin Sodium for Injection: Prevention of Inflammation in Rats after Castration, supplied by North China Pharmaceutical Co., Ltd. Specifications: 800,000 units (0.48g).

[0023] 1.2 Experimental animals

[002...

Embodiment 2 7

[0054] The clinical research of embodiment 2 aescin sodium

[0055] 1. Basic information of the case

[0056] A total of 60 outpatients with type Ⅲ prostatitis were recruited, aged from 20 to 55 years old. The longest course of disease was 25 years, and the shortest was 1 year. Some patients had used other therapeutic drugs, but the curative effect was not good. All cases met the inclusion criteria of the study protocol.

[0057] 2. Patient inclusion criteria

[0058] (1) Lower urinary tract symptoms such as frequent urination, urgency, painful urination, poor urination, incomplete urination, increased nocturia, pain and discomfort in the lower limbs, groin area, lumbosacral region, scrotum, testes, and perineum, and even loss of libido, Male outpatients with chronic prostatitis (type Ⅲ) symptoms such as premature ejaculation and ejaculation pain, which last for more than 8 weeks, aged between 20 and 55;

[0059] (2) National Institutes of Health chronic prostatitis symptom...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a novel application of aescin and salt thereof in pharmacy, in particular relates to the novel application of aescin and salt thereof in preparing alpha-blocker medicaments and medicaments for treating chronic abacterial prostatitis. Pharmacodynamic experiment results indicate that aescin and salt thereof can be used for reducing the prostate organ coefficient of a rat model with chronic abacterial prostatitis caused by an estradiol benzoate injection, reducing the number of leukocytes in the prostate of the rat model with chronic abacterial prostatitis, and improving the density of the lecithin body in the prostate of the rat model. Clinical testing results indicate that the aescin and salt thereof can be used for relaxing prostate and bladder smooth muscle and have effects similar to alpha-blocker (bensylyt), the total effective rate of the aescin and salt thereof for treating chronic abacterial prostatitis is 88.33 percent, which is superior to that of the alpha-blocker bensylyt, and no remarkable adverse response is found.

Description

technical field [0001] The present invention mainly relates to the new application of aescin and its salt, in particular to the new application of aescin and its salt in the preparation of α-receptor blocker medicine and the medicine for treating chronic non-bacterial prostatitis. Background technique [0002] Aescin, also known as aescinic acid, is a general term for total saponins, β-aescin or isoescin, which are extracted from the seeds of Aesculus in the family Aesculus. At present, total sodium aescinate is mostly used in clinical practice, which mainly contains 4 kinds of ingredients. According to the national standard of our country, it is named as aescin A, aescin B, aescin C and aescin D successively according to the peak of liquid chromatography. Among them, aescin A and B are β-type aescins, and their structures are basically the same, so aescins A and B can be combined and represented by structural formula (1); and aescins C and D are also isomers of each other,...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/704A61P13/08A61P29/00
Inventor 刘享平石召华张蕊叶利春王方陈立军
Owner WUHAN AIMIN PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com